Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs Compugen Ltd. (CGEN)

ADC Therapeutics SA and Compugen Ltd. are both Biotechnology companies. ADC Therapeutics SA and Compugen Ltd. are of similar size ($197.0M and $190.2M). ADC Therapeutics SA has negative trailing earnings, so its P/E is not meaningful; Compugen Ltd. trades at 5.2×. Compugen Ltd. grew revenue faster over the last twelve months: 234.2% against 3.03%. Compugen Ltd. has the higher net margin (47.6% vs −121.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Compugen Ltd. leads on 14 and ADC Therapeutics SA on 2.

Valuation

Metric ADCT CGEN Biotechnology median
P/E n/m 5.16 8.50
P/S 2.75 2.51 9.71
P/B n/m 2.09 2.13
Price to free cash flow n/m 4.63 20.82
EV/EBITDA n/m 1.99 0.64
EV/Sales 1.46 0.81 9.21
Earnings yield (46.81%) 19.39% (33.15%)
Free cash flow yield (46.54%) 21.58% (25.50%)

Profitability

Metric ADCT CGEN Biotechnology median
Gross margin 88.86% 86.89% 65.16%
Operating margin (125.08%) 40.94% 0.00%
Net margin (121.77%) 47.55% 0.00%
Free cash flow margin (127.72%) 54.10% 0.00%
Return on equity 45.35% 47.85% (56.36%)
Return on assets (32.25%) 23.86% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADCT CGEN Biotechnology median
Revenue growth (TTM) 3.03% 234.18% 6.02%
EPS growth (last fiscal year) 30.86% 337.50% 30.26%
Revenue growth, 5-year CAGR 103.35% 105.20% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADCT CGEN Biotechnology median
Debt to equity (0.51) 0.00 0.00
Current ratio 3.03 5.72 4.72
Net debt to EBITDA 1.22 (4.65) 0.96

Dividend

Metric ADCT CGEN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADCT CGEN Biotechnology median
Market cap 190.23m 197.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack